Bio-Rad Laboratories Current Ratio 2010-2022 | BIO.B
Current and historical current ratio for Bio-Rad Laboratories (BIO.B) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bio-Rad Laboratories current ratio for the three months ending December 31, 2022 was 5.55.
| Bio-Rad Laboratories Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2022-12-31 |
$3.16B |
$0.57B |
5.55 |
| 2022-09-30 |
$3.14B |
$0.57B |
5.50 |
| 2022-06-30 |
$3.25B |
$0.61B |
5.30 |
| 2022-03-31 |
$3.30B |
$0.65B |
5.10 |
| 2021-12-31 |
$1.99B |
$0.68B |
2.92 |
| 2021-09-30 |
$2.47B |
$0.65B |
3.80 |
| 2021-06-30 |
$2.29B |
$0.59B |
3.90 |
| 2021-03-31 |
$2.18B |
$0.61B |
3.57 |
| 2020-12-31 |
$2.14B |
$0.63B |
3.39 |
| 2020-09-30 |
$2.32B |
$0.99B |
2.36 |
| 2020-06-30 |
$2.13B |
$0.93B |
2.30 |
| 2020-03-31 |
$2.08B |
$0.87B |
2.40 |
| 2019-12-31 |
$2.18B |
$0.91B |
2.41 |
| 2019-09-30 |
$2.05B |
$0.43B |
4.72 |
| 2019-06-30 |
$2.09B |
$0.45B |
4.68 |
| 2019-03-31 |
$2.03B |
$0.44B |
4.57 |
| 2018-12-31 |
$2.02B |
$0.45B |
4.49 |
| 2018-09-30 |
$2.03B |
$0.45B |
4.49 |
| 2018-06-30 |
$1.99B |
$0.44B |
4.50 |
| 2018-03-31 |
$1.98B |
$0.46B |
4.33 |
| 2017-12-31 |
$1.98B |
$0.50B |
3.93 |
| 2017-09-30 |
$1.89B |
$0.47B |
4.06 |
| 2017-06-30 |
$1.83B |
$0.46B |
4.01 |
| 2017-03-31 |
$1.73B |
$0.41B |
4.25 |
| 2016-12-31 |
$1.85B |
$0.47B |
3.91 |
| 2016-09-30 |
$1.85B |
$0.44B |
4.18 |
| 2016-06-30 |
$1.81B |
$0.41B |
4.40 |
| 2016-03-31 |
$1.78B |
$0.40B |
4.43 |
| 2015-12-31 |
$1.78B |
$0.44B |
4.03 |
| 2015-09-30 |
$1.79B |
$0.44B |
4.12 |
| 2015-06-30 |
$1.74B |
$0.40B |
4.31 |
| 2015-03-31 |
$1.70B |
$0.42B |
4.08 |
| 2014-12-31 |
$1.72B |
$0.45B |
3.84 |
| 2014-09-30 |
$1.76B |
$0.50B |
3.50 |
| 2014-06-30 |
$1.77B |
$0.48B |
3.68 |
| 2014-03-31 |
$1.77B |
$0.48B |
3.67 |
| 2013-12-31 |
$1.76B |
$0.49B |
3.61 |
| 2013-09-30 |
$1.68B |
$0.46B |
3.62 |
| 2013-06-30 |
$1.90B |
$0.43B |
4.41 |
| 2013-03-31 |
$1.87B |
$0.45B |
4.18 |
| 2012-12-31 |
$1.94B |
$0.47B |
4.10 |
| 2012-09-30 |
$1.85B |
$0.43B |
4.26 |
| 2012-06-30 |
$1.81B |
$0.42B |
4.34 |
| 2012-03-31 |
$1.82B |
$0.44B |
4.09 |
| 2011-12-31 |
$1.80B |
$0.46B |
3.92 |
| 2011-09-30 |
$1.88B |
$0.42B |
4.52 |
| 2011-06-30 |
$1.89B |
$0.44B |
4.27 |
| 2011-03-31 |
$1.80B |
$0.43B |
4.20 |
| 2010-12-31 |
$1.98B |
$0.67B |
2.96 |
| 2010-09-30 |
$1.65B |
$0.41B |
4.02 |
| 2010-06-30 |
$1.56B |
$0.39B |
3.99 |
| 2010-03-31 |
$1.54B |
$0.40B |
3.88 |
| 2009-12-31 |
$1.56B |
$0.42B |
3.72 |
| 2009-09-30 |
$1.50B |
$0.42B |
3.62 |
| 2009-06-30 |
$1.40B |
$0.38B |
3.64 |
| 2009-03-31 |
$1.05B |
$0.36B |
2.95 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$13.735B |
$2.802B |
|
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
|
